Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01787214 · ClinicalTrials.gov registry record · NA

Walnuts and Glucose Variability

A NA study, sponsored by Loma Linda University.

Terminated
Registry status
NA
Development phase
18
Enrollment target

NCT01787214 is a NA study that was terminated before completion, run by Loma Linda University. The registered enrollment target is 18 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01787214, a NA study, was terminated before completion, sponsored by Loma Linda University.

TERMINATED
Registry status
NA
Development phase
18 participants
Enrollment target

Study Summary

Persons with type 2 diabetes mellitus (T2DM) have swings in their blood sugar levels that may lead to a higher risk of developing heart disease. An important part of diabetes management involves eating a diet to prevent large swings in blood sugar levels. Walnuts contain fat, protein and fiber that may reduce the swings in blood sugar. The purpose of this study is to compare the effects of a walnut-free American Diabetes Association (ADA) diet versus 2 levels of walnut-enriched ADA diets on blood sugar swings. Eighteen male and female adults with T2DM will participate in the study. Subjects will be randomized to consume an ADA diet with or without walnuts for 3 consecutive days every other week. Subjects must test their blood sugar twice daily and wear a continuous glucose monitor during the three 72-hour study periods. Subjects will be between 40 and 70 years of age and will be recruited from the surrounding community using flyers and public service announcements. Consent will take place in the Department of Nutrition at Loma Linda University by the study investigators. In total, subject participation will last 5 weeks and all meals will be provided during the 3 study periods.

Interventions

  • DIETARY_SUPPLEMENT Control
  • DIETARY_SUPPLEMENT Full dose
  • DIETARY_SUPPLEMENT Half dose

Trial Details

FieldValue
Enrollment Target 18 participants
Start Date 2013-06
Est. Completion 2013-09
Phase NA

Sponsor

Loma Linda University

237 total trials

What the Registry Record Tells You About NCT01787214

The ClinicalTrials.gov registry entry for NCT01787214 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loma Linda University, which has 237 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.

NCT01787214 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01787214 about?

NCT01787214 is a clinical study titled "Walnuts and Glucose Variability". Persons with type 2 diabetes mellitus (T2DM) have swings in their blood sugar levels that may lead to a higher risk of developing heart disease. An important part of diabetes management involves eating a diet to prevent large swings in blood sugar levels. Walnuts contain fat, protein and fiber that ...

What is the current status of trial NCT01787214?

This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2013-06. Estimated completion is 2013-09.

What interventions are being tested in trial NCT01787214?

The interventions under investigation include: Control (DIETARY_SUPPLEMENT), Full dose (DIETARY_SUPPLEMENT), Half dose (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT01787214?

This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.